| Microcavity-assisted cloning (MAC) of hard-to-clone HepG2 cell lines : cloning made easy | BMC biotechnology |  | | 2024 | 35 | 282 |
|
| 17q Gain in Neuroblastoma : A Review of Clinical and Biological Implications | Cancers | | | 2024 | 34 | 209 |
|
| Neuroblastoma response to RAS-MAPK inhibitors and APR-246 (eprenetapopt) co-treatment is dependent on SLC7A11 | Frontiers in oncology | | | 2024 | 30 | 485 |
|
| GSTM1 and GSTT1 double null genotypes determining cell fate and proliferation as potential risk factors of relapse in children with hematological malignancies after hematopoietic stem cell transplantation | Journal of cancer research and clinical oncology | | | 2022 | 404 | 222 |
|
| The Catalytic Activity of GSTM1 In vitro is Independent of MAPK8 | Drug metabolism letters | | | 2021 | 115 | 132 |
|
| A review of the biological and clinical implications of RAS-MAPK pathway alterations in neuroblastoma | Journal of experimental & clinical cancer research | | | 2021 | 260 | 423 |
|
| The analysis of GSTA1 promoter genetic and functional diversity of human populations | Scientific reports | | | 2021 | 294 | 470 |
|
| 4th ESPT Conference: pharmacogenomics and personalized medicine - research progress and clinical implementation | Pharmacogenomics | | | 2019 | 326 | 709 |
|
| The Biological and Clinical Relevance of G Protein-Coupled Receptors to the Outcomes of Hematopoietic Stem Cell Transplantation: A Systematized Review | International Journal of Molecular Sciences | | | 2019 | 348 | 363 |
|
| PRIMA-1MET-induced neuroblastoma cell death is modulated by p53 and mycn through glutathione level | Journal of Experimental & Clinical Cancer Research | | | 2019 | 332 | 460 |
|
| 4th ESPT summer school: precision medicine and personalised health | Pharmacogenomics | | | 2019 | 285 | 156 |
|
| 11q deletion in neuroblastoma: a review of biological and clinical implications | Molecular Cancer | | | 2017 | 505 | 450 |
|
| Creation of the Swiss group of Pharmacogenomics and personalised Therapy (SPT) | Drug Metabolism and Personalized Therapy |  | | 2017 | 550 | 1 |
|
| GSTA1 diplotypes affect busulfan clearance and toxicity in children undergoing allogeneic hematopoietic stem cell transplantation: a multicenter study | Oncotarget | | | 2017 | 569 | 354 |
|
| The Association of Combined GSTM1 and CYP2C9 Genotype Status with the Occurrence of Hemorrhagic Cystitis in Pediatric Patients Receiving Myeloablative Conditioning Regimen Prior to Allogeneic Hematopoietic Stem Cell Transplantation | Frontiers in Pharmacology | | | 2017 | 632 | 303 |
|
| 8th Santorini Conference: Systems medicine and personalized health and therapy, Santorini, Greece, 3-5 October 2016 | Drug Metabolism and Personalized Therapy | | | 2017 | 590 | 3 |
|
| Pharmacogenomics in Pediatric Oncology: Review of Gene-Drug Associations for Clinical Use | International Journal of Molecular Sciences | | | 2016 | 599 | 687 |
|
| Creation of the Swiss group of pharmacogenomics and personalized therapy (SPT) | Paediatrica | | | 2016 | 403 | 152 |
|
